Molecular & Nucleic Acid Testing Market Reports

Find the information you need on molecular and nucleic acid testing. The Kalorama Information collection of market research reports provides insights into product trends, analyses, opportunities, and projections. Specifics on market share, segmentation, size, and growth in the US and global markets are also featured.

Title	Published	Price
The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles) Clinical laboratories are an essential part of the health industry. It is estimated that approximately 80% of physician's diagnoses are a result of laboratory tests. The constant pressure to reduce healthcare spending is shifting healthcare utilization in favor of the laboratory, making it an ever more valuable part of the  |  more... Search inside this report	Feb 1, 2010	$3,500.00
2009 Worldwide Diagnostics Market Research Bundle What does the diagnostic market look like today, how is the continuing economic news effecting the market, and what are companies doing right now to prosper? This diagnostic industry market research bundle, with over 1,200 pages, seeks to answer these questions and provide market watchers with the most comprehensive  |  more... Search inside this report	Oct 1, 2009	$5,995.00
Infectious Disease Diagnostic Markets The ubiquity of infections makes thier detection a healthcare priority and an ongoing opportunity for IVD companies. The aging of the population, and emerging threats - MRSA, swine flu, and others have had an impact on this market recently and will continue to in years to come. Kalorama  |  more... Search inside this report	Aug 1, 2009	$3,500.00
H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays) The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert  |  more... Search inside this report	May 1, 2009	$800.00
Who's Doing What in Molecular Diagnostics? - The Results of the Kalorama Information/Emmes Group Survey of U.S. Laboratories From Kalorama Information a unique tool for assessing the diagnostic business today. Working in conjunction with premier diagnostic survey database Emmes Group, Kalorama Information presents the summarized results from a recent survey of a critical mass of diagnostic labs in the U.S, with analysis from Kalorama's leading  |  more... Search inside this report	Apr 1, 2009	$4,995.00
The World Market for Molecular Diagnostics Molecular diagnostics represents a revolution postponed, perhaps, but one that is now clearly underway. DNA Testing has emerged fully from research into clinical practice and becoming a dominant platform in clinical medicine. From Emerging to Emergent Technology Instrumentation now automates many of the sample preparation  |  more... Search inside this report	Jan 1, 2009	$3,995.00
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 6th Edition [with 2009 economy preface] This edition of Kalorama’s comprehensive and indispensable report covers the breadth of traditional IVD testing. The report contains complete market statistics and analysis for all areas of IVD, including: Point-of-Care Core Lab Immunoassays Molecular Assays Hematology Coagulation Microbiology and Virology Blood Banking  |  more... Search inside this report	Dec 1, 2008	$3,995.00
IVD Market Research Supplement : Testing Services Markets, SNP Analysis, DNA Sequencing, Retail Clinics, Companion Diagnostics A perfect supplemental information resource for customers who have already purchased The Worldwide Market for In Vitro Diagnostic Tests, 6th Edition, The IVD Market Research Supplement bundle studies and quantifies in greater detail some of the important areas that will have a transforming impact on the diagnostic industry:  |  more... Search inside this report	Aug 1, 2008	$8,995.00
Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in 'Theranostics' and Personalized Medicine) This Kalorama Information report, Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine) is truly a real-world guide to the potential market for companion diagnostics. Essentially the co-development of testing products to enhance the value and efficacy of a  |  more... Search inside this report	Jun 1, 2008	$2,995.00
Molecular Diagnostics in China For 12+ years, the team of Carl McEvoy and Michael Farmer have conducted exhaustive on-the-ground research in Asia, and most notabably China, interviewing lab employees and executives to obtain an accurate picture of the IVD market in China and other countries. In cooperation with Kalorama Information this report Molecular  |  more... Search inside this report	Feb 1, 2008	$4,000.00
Early Toxicology: Markets and Approaches Toxicity is a crucial parameter that is measured throughout the drug development process. Toxic side-effects are one of the most common reasons drug candidates fail. Toxicity can be a factor of dose, the form in which the drug is administered, and the time of exposure before elimination. Patient  |  more... Search inside this report	Jun 1, 2007	$2,800.00
Clinical Diagnostics in India: Market Sector Analyses and Participant Directory The current population of India is 1.065 billion, and with a growth rate of 1.7%, India will surpass China to become the world’s largest country around 2030. For diagnostic manufacturers, this enormous market is just now being recognized as a high-growth area as the pace of economic growth in India  |  more... Buy by the section | Search inside this report	Dec 1, 2006	$4,500.00
Molecular Imaging Agents and Systems: A Market Briefing Interest in and use of the technology has exploded in recent years, thanks to advances in cell biology, biochemical agents, and computer analysis. Research groups around the world are joining the effort to use magnetic, nuclear, and optical imaging techniques to study the molecular interactions that underlie biological processes.  |  more... Search inside this report	Jun 1, 2005	$995.00
Cell-Based Diagnostics: Technology, Applications, and Markets This report covers clinical and drug discovery assay systems that use cells as the basic source material. Sources of the cells to be studied include peripheral blood, cord blood, bone marrow, urine, cerebrospinal and other body fluids and tissue samples. Cell analysis is not a new laboratory procedure. Clinical  |  more... Buy by the section | Search inside this report	Jan 1, 2005	$3,500.00
Molecular Diagnostics for Inherited Disease Testing: Testing volume, cost per test, and market potential Gene and chromosome testing for inherited diseases currently represents the third largest molecular diagnostics testing segment in the U.S. Assays in this market address applications in genetic carrier and predisposition testing. Currently, most testing is for prenatal screening and for assessing clinically  |  more... Search inside this report	Oct 1, 2004	$995.00
Molecular Diagnostics for Infectious Disease Testing: Testing volume, cost per test, and market potential Currently, the largest market application segment for molecular diagnostics is that for infectious disease testing. The segment is expected to grow at an annual rate between 7% and 8% over the next few years will present some excellent market opportunites for molecular diagnostic competitors.  |  more... Search inside this report	Oct 1, 2004	$995.00
Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential The field of pharmacogenetics promises to open up new opportunities for the diagnostic industry at the same time it opens the door to more effective therapeutics. Pharmacogenetics is based on the principle that the effects of a given medication when administered to a patient are determined, at least in part,  |  more... Search inside this report	Oct 1, 2004	$995.00
U.S. Market for Molecular Diagnostics, 2nd Edition Molecular diagnostics are seen as being a major breakthrough in medical science. While the technology itself has broad applications to such areas as agricultural bioterrorism and environmental science, medical and medical research applications have provided the primary focus. As a result, great things have been predicted for the  |  more... Buy by the section | Search inside this report	May 1, 2004	$3,500.00
Advanced Polymers for Medical Applications: Materials, Product Development, and Market Opportunities In virtually all areas of medicine, increasingly sophisticated devices are turning to increasingly sophisticated materials science to solve their most nagging technical problems. From passive functions like sterility and biocompatibility to active drug delivery and even conductivity, polymers are proving to be more versatile and complex than ever before. Kalorama's  |  more... Buy by the section | Search inside this report	Feb 1, 2002	$2,625.00
Diabetes and Diabetic Complications: Major World Markets The global market for diabetes products, particularly new therapeutics and monitoring products, is a large and growing one. This growth is fueled by three factors --- (1) a rapidly increasing patient population; (2) a back-log of unmet needs, particularly with regard to therapeutics; and (3) advances in biomedical  |  more... Buy by the section | Search inside this report	Jan 1, 2002	$2,625.00
The U.S. Market for Molecular Diagnostics In recent years molecular diagnostics has become a growing part of the clinical laboratory. The trend will not only continue but will show significant growth in the future. This report from Kalorama Information examines the current and future opportunities associated with Molecular Diagnostic Technologies. Areas covered include: Applications  |  more... Buy by the section | Search inside this report	Oct 1, 2001	$2,750.00
Trends in the Early Diagnosis of Cardiovascular Disease: Worldwide Market Opportunities Despite dramatic improvements in both diagnosis and therapy, cardiovascular disease remains the leading cause of mortality in the developed world. Worldwide more than $54 billion was spent on cardiac care therapeutics in 1999, with an expected 10% annual increase for the next 10 to 15 years. Furthermore, U.S. government statistics  |  more... Buy by the section | Search inside this report	Oct 1, 2001	$3,250.00
Title	Published	Price